Literature DB >> 14506237

The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression.

Claire K Inman1, Paul Shore.   

Abstract

Targeted deletion of the Runx2 gene in mice has demonstrated that Runx2 is a master regulator of osteoblast differentiation. Runx2 has therefore largely been regarded as a bone-specific transcription factor. Runx2-/- mice die shortly after birth and therefore the role of Runx2 in later developing tissues remains unclear. Here we show that the Runx2 protein is expressed in several mammary epithelial cell lines and in primary mammary epithelial cells. In addition, we have also found that it has a functionally important role in gene regulation. Osteopontin (OPN) is expressed in mammary epithelial cells during pregnancy and lactation and has been shown to have a role in mammary gland differentiation. Here we show that a Runx2 site in the OPN promoter is required for activation of the promoter in mammary epithelial cells. Moreover, dominant-negative Runx proteins can inhibit both activation of an OPN promoter reporter in transient transfections and expression of the endogenous OPN gene in mammary epithelial cells. Our data suggest, for the first time, that the osteoblast transcription factor Runx2 has a role in the normal regulation of gene expression in mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506237     DOI: 10.1074/jbc.M308001200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.

Authors:  M Tandon; Z Chen; A H Othman; J Pratap
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

2.  Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein.

Authors:  Claire K Inman; Na Li; Paul Shore
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals.

Authors:  Laura L Hernandez; Karen A Gregerson; Nelson D Horseman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

4.  Alternative splicing in bone following mechanical loading.

Authors:  Sara M Mantila Roosa; Yunlong Liu; Charles H Turner
Journal:  Bone       Date:  2010-11-21       Impact factor: 4.398

5.  Glucose-activated RUNX2 phosphorylation promotes endothelial cell proliferation and an angiogenic phenotype.

Authors:  Adam D Pierce; Ian E Anglin; Michele I Vitolo; Maria T Mochin; Karen F Underwood; Simeon E Goldblum; Sravya Kommineni; Antonino Passaniti
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

6.  Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.

Authors:  Jitesh Pratap; John J Wixted; Tripti Gaur; Sayyed K Zaidi; Jason Dobson; Karthiga Devi Gokul; Sadiq Hussain; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

7.  The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.

Authors:  Daniel Mendoza-Villanueva; Wensheng Deng; Cesar Lopez-Camacho; Paul Shore
Journal:  Mol Cancer       Date:  2010-06-30       Impact factor: 27.401

Review 8.  Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.

Authors:  Akeila Bellahcène; Vincent Castronovo; Kalu U E Ogbureke; Larry W Fisher; Neal S Fedarko
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

Review 9.  Prostate cancer regulatory networks.

Authors:  Dario C Altieri; Lucia R Languino; Jane B Lian; Janet L Stein; Irwin Leav; Andre J van Wijnen; Zhong Jiang; Gary S Stein
Journal:  J Cell Biochem       Date:  2009-08-01       Impact factor: 4.429

10.  Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.

Authors:  J Akech; J J Wixted; K Bedard; M van der Deen; S Hussain; T A Guise; A J van Wijnen; J L Stein; L R Languino; D C Altieri; J Pratap; E Keller; G S Stein; J B Lian
Journal:  Oncogene       Date:  2009-11-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.